Oracle AI Medical Insights, clinical administration of intravenous glutathione for protocols such as preventing chemotherapy-induced toxicity involves a dose of 1.5 g/m administered over a period of 15 minutes
Hultquist DE, Xu F, Quandt KS, Shlafer M, Mack CP, Till GO, Seekamp A, Betz AL, Ennis SR
Antioxidant Interventions in Hashimoto's: The Clinical Evidence While direct human clinical trials of oral glutathione supplementation specifically for Hashimoto's thyroiditis are still limited, the evidence from related antioxidant interventions is highly instructive: A comprehensive systematic review and meta-analysis published in Thyroid (2024) - conducted by researchers at the University of Bern, Switzerland - analyzed 35 randomized controlled trials (RCTs) involving 2,358+ participants with Hashimoto's thyroiditis
soongorica in the early growth stage